| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Outlook and Strategy of Indian Stock Exchange Market 2006-2007 |
|
Just Other Articles - Outlook and Strategy of Indian Stock Exchange Market 2006-2007
Indian Stock Market occupied a top slot in 2006, together with an unexpected fluctuation with sudden rise and fall, but maintained the sensex mar According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product k. In 2006, the Bombay Stock Exchange crossed the 10,000 level mark. There were speculations amongst the bulls at the Dalal Street (Mumbai) that ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ensex might cross 14,000 marks, but unfortunately the year 2006 ended with the average 12,500 level. Fundamentally strong, the economy was the ma lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. n key but raising inflation rate and high crude oil prices applied brakes on its acceleration. The Indian stock market raised to dizzy heights i here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe a span of 194 days, from October 28, 2005 to May 10, 2006, with the BSE sensex rising from 7686 points to 12612 points, a gain of 4962 points. I d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro then fell very fast to a level of 8929 points on June 14, 2006, registering a loss of 3683 points in 35 days. It has again reached a level of 12 ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc 10 on September15, 2006, again of 3086 points in a span of 93 days and presently the market is trading in the region of 13250.Like April 2006, so easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e felt that when the market rose high, that time has come for a correction and the market was totally overheated. Investors were of the view that nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically when the market started falling and a negative sign was taking up, it could reach up to 9000 level, but the sensex has bounced back and reached 1 and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ 321 points on last September 27,2006. There are concerns over tight global liquidity and deteriorating trade balance. These may not check India’ ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi strong economic growth. As India is getting younger and younger, its productivity is bound to rise. Investment in Indian market must be seen in ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a a marginally different context. As much as 60 percent of the GDP is led by domestic consumption whereas other emerging countries are dependent on dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod foreign market. For the next few months ending the financial year 2007,sectors like FMCG,pharma,retail,media and textiles looks attractive in ter cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s of valuation.Basically,India ,a service driven growth story, has enough to offer since we are in the middle of a capital expenditure boom and r tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen pidly expanding outsourcing. India’s growth will be sustained and may reach greater levels if the government act on reforms front.Infrastructure t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ports, roads, SEZ etc requires more attention and investment. Investment in 2007 will be the brighter period for any investor. Going by the fund ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust mentals, most experts believe that for the next 6 to 8 months there is very limited downside risk at the current level. As per the Morgan Stanley y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products s report, technically speaking, this quarterly period (June2007), the Sensex would reach the point 14700.Also in the near future, the Indian stoc . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de market will see foreign companies raising funds through Indian Depository Receipts (IDR).But at the same time we can see that the Indian capital elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Market is characterized by its high degree of volatility which has been instrumental in both creating and destroying the wealth of many investors tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Vending Machine Consumer Perceptions Improve Your Business Writing Skills Immediately - Try These Seven Tips
|